| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 10, 2025
Findings highlight the potential of new investigational waveforms for the all-in-one mapping and dual-energy ablation system in advancing treatment for ventricular arrhythmia patients
-
Mar 28, 2025
New investigational energy waveforms created specifically to target ventricular arrhythmias
Ventricular arrhythmia research will provide important clinical evidence using a new technology for patient population in need of new treatment options
-
Jan 17, 2025
Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter
Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally
Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion
-
Oct 11, 2024
The VT research will provide important clinical evidence in an underserved patient population
-
Aug 22, 2024
Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile
-
Feb 1, 2024
Physician feedback confirms clinical evidence: safe, efficient, and effective treatment offers most versatile new option for atrial fibrillation
-
Nov 20, 2023
Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation
-
May 19, 2023
Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System
-
Apr 16, 2023
12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter
-
Apr 27, 2022
Medtronic today announced that it has signed an agreement with Acutus Medical Inc., a manufacturer of arrhythmia management technologies, for exclusive rights to distribute and acquire its...
